Neuromics is pleased to announce the release of five new human cell types for research in diabetes and obesity. This introduction builds on an existing inventory of human cells, specifically endothelial cells, which have a long history of being utilized to study diabetes and obesity (learn more).
Our new selection offers unique opportunities for disease-specific models, as we've chosen Adipose-Derived Stem Cells (ADSCs), fibroblasts, and hepatic stellate cells isolated from diseased donors. The cells are suited for any researcher studying type 1 diabetes, type 2 diabetes, obesity, or non-alcoholic steatohepatitis (NASH).
Image: Formation of tube networks in Neuromics HRMECs in normal glucose (NG) and high glucose (HG) conditions.
Here are the new cell types:
Along with the cells, we offer a comprehensive range of growth media, coating solutions, and more to facilitate their growth.
The release of these new cell types will build on the existing use of our cells to study these common diseases. If you are interested in the cells or have any questions, please do not hesitate to contact us.
| Name | Catalog # | Type | Species | Applications | Size | Price |
|---|---|---|---|---|---|---|
| Human ADSCs (Obesity Donor) | ADSC001 | Stem Cells | Human | Cell Assays | 1,000,000 Cells | $3,125.00 |
| Human ADSCs (Type 1 Diabetes Donor) | ADSC002 | Stem Cells | Human | Cell Assays | 1,000,000 Cells | $2,850.00 |
| Human ADSCs (Type 2 Diabetes Donor) | ADSC003 | Stem Cells | Human | Cell Assays | 1,000,000 Cells | $2,990.00 |
| Human Dermal Fibroblasts (Type 1 Diabetes) | HDF002 | Primary Cells | Human | Cell Assays | 500,000 Cells | $2,850.00 |
| Human Hepatic Stellate Cells (NASH) | HHSC001 | Primary Cells | Human | Cell Assays | 1,000,000 Cells | $3,330.00 |